Effect of a Lactobacillus salivarius probiotic on a double-species Streptococcus mutans and Candida albicans caries biofilm by Krzyściak, Wirginia et al.
nutrients
Article
Effect of a Lactobacillus Salivarius Probiotic on
a Double-Species Streptococcus Mutans and
Candida Albicans Caries Biofilm
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Abstract: The aim of the study was to evaluate the anti-cariogenic effects of Lactobacillus salivarius
by reducing pathogenic species and biofilm mass in a double-species biofilm model. Coexistence of
S. mutans with C. albicans can cause dental caries progression or recurrence of the disease in the
future. Fifty-nine children with diagnosed early childhood caries (ECC) were recruited onto the study.
The condition of the children’s dentition was defined according to the World Health Organization
guidelines. The participants were divided into children with initial enamel demineralization and
children showing dentin damage. The study was performed on the S. mutans and C. albicans clinical
strains, isolated from dental plaque of patients with ECC. The effect of a probiotic containing
Lactobacillus salivarius on the ability of S. mutans and C. albicans to produce a double-species biofilm
was investigated in an in vitro model. The biomass of the formed/non-degraded biofilm was
analyzed on the basis of its crystal violet staining. The number of colonies of S. mutans and
C. albicans (CFU/mL, colony forming units/mL) forming the biofilm was determined. Microorganism
morphology in the biofilm was evaluated using a scanning electron microscope (SEM). In vitro
analysis demonstrated that the presence of S. mutans increased the number of C. albicans colonies
(CFU/mL); the double-species biofilm mass and hyphal forms produced in it by the yeast. L. salivarius
inhibited the cariogenic biofilm formation of C. albicans and S. mutans. Under the influence of the
probiotic; the biofilm mass and the number of S. mutans; C. albicans and S. mutans with C. albicans
colonies in the biofilm was decreased. Moreover; it can be noted that after the addition of the
probiotic; fungi did not form hyphae or germ tubes of pathogenic potential. These results suggest
that L. salivarius can secrete intermediates capable of inhibiting the formation of cariogenic S. mutans
and C. albicans biofilm; and may inhibit fungal morphological transformation and thereby reduce the
pathogenicity of C. albicans; weakening its pathogenic potential. Further research is required to prove
or disprove the long-term effects of the preparation and to achieve preventive methods.
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1. Introduction
Early childhood caries (ECC) is one of the most widespread infectious diseases associated with
biofilm formation in children worldwide—in Poland, it is prevalent in over 85% of pre-school children
(<6 years) [1,2]. Untreated, ECC can lead to rapid tooth damage, causing pain and dangerous systemic
infections [3]. Despite preventive measures and dental interventions, the first signs of ECC create
a high risk of future recurrences [4], generating health and economic burdens among people at risk.
As proposed by the FAO/WHO (Food and Agriculture Organization of the United Nations,
World Health Organization) definition, probiotics are live microorganisms, not causing any adverse
effects on the organism and provide health benefits when administered in appropriate amounts [5].
Currently, interest in probiotic usage, in the case of caries prophylaxis, is growing, but their clinical
efficacy in disease prevention appears limited and controversial [6,7]. Research on the use of probiotics
in caries focuses primarily on their mechanism of growth inhibition and dental plaque reduction,
created by pioneer Streptococcus mutans (S. mutans) strains, which are the main etiologic agent of this
disease [8]. Even in clinical trials, endpoints usually constitute indirect measurements and are mainly
associated with a decrease in S. mutans in the saliva [9–11] or a reduction of dental plaque acidity [12].
They do not affect the improvement of tooth enamel mineralization or the inhibition of plaque
formation, which seems to be more adequate in the context of permanent (residential) colonization of
S. mutans at the site of developing caries lesions (in plaque but not saliva). Bacteria, such as S. mutans
as well as Candida genus fungi, present in the saliva (suspended as planktonic forms) are not direct
etiologic factors of oral diseases [13]. Saliva is a material that only contains the transient presence of
cariogenic bacteria or opportunistic fungi of the Candida genus and mediates the invasion of pathogenic
bacteria in inflammatory foci [14].
In several clinical trials, the administration of Lactobacillus genus (L. reuteri, L. salivarius,
L. rhamnosus) probiotics has demonstrated a decrease in the intensity of caries in
children [10,15,16]. However, certain literature data show the reverse effects of the administration of
Lactobacillus-containing probiotics (including L. rhamnosus, L. reuteri, and L. paracasei), due to the lack
of S. mutans inhibition [17–19].
Probiotics contain microorganisms that do not show negative effects on the body; instead, they
affect the human microflora through various mechanisms. They compete with other bacteria for
nutrients and binding sites to the medium, inhibit their growth by producing bacteriocins, and
further stimulate the immune response of the host. This occurs through the possible control of
cytokine over-expression [20–22]. Nevertheless, the use of probiotics in immunocompetent hosts seems
controversial, because of the reported cases of generalized infections from probiotic strains [20,23].
Indeed, Candida albicans (C. albicans) and S. mutans coexist for early childhood caries (ECC) [24,25].
On one hand, Candida-derived β-1,3-glucans affect the structure of the exopolysaccharide matrix (EPS),
while mannan and β-glucan provide binding sites for glucosyltransferase B (GtfB). Candida albicans
occurs in 96% of children with caries (age: 6–12 years), but only in 24% of children without this
disease [26]. Currently, no in vivo studies have been conducted to demonstrate mutual interactions
between S. mutans and C. albicans in models similar to actual oral cavity conditions in children
with caries.
Oral streptococci produce proteins anchored in the cell wall to facilitate binding to C. albicans [27].
There is a specific hyperadditive effect of S. oralis and C. albicans during the fungi supported
streptococcal biofilm production on mucous membranes [28]. Thus, not only mutants, but also
species, such as C. albicans, can be decisive in determining the cariogenicity of the formed biofilms [29].
This was confirmed by recent studies, which demonstrated that increased Candida was associated
with reduced diversity of salivary microbiota and displacement of the microbial aggregate toward
streptococci [30].
Probiotics aggravate or delay the colonization of pathogenic bacteria during biofilm
formation [31,32]. The mechanism of coaggregation of S. mutans with other bacteria has been
intensively investigated, but there are few studies evaluating the effect of probiotics on this process.
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These focus mainly on the ability to inhibit mono-species biofilms or they evaluate the effects
of probiotics only on salivary S. mutants, without evaluation of their relationships with an oral
microbiome [33–35].
The limited number of studies on mutual interactions between clinical S. mutans and C. albicans
strains in cariogenic biofilms and the effects of the probiotic L. salivarius on such interactions prompted
us to address this problem.
The aim of the study was to evaluate the effect of a probiotic containing Lactobacillus salivarius
on the mutual interactions of S. mutans and C. albicans as well as the ability to form a double-species
biofilm, isolated from clinical strains, in an in vitro model.
2. Materials and Methods
2.1. Study Group
The examination was conducted according to the guidelines outlined in the Helsinki Declaration
of 2008. The material was collected after the written consent of all participants (children and parents as
their legal guardians). The Bioethics Committee of the Jagiellonian University in Krakow approved
the study protocol (No. 122.6120.99.2016.).
The study was conducted from December 2016 to May 2017, involving a total of 59 pediatric
subjects who had been screened/examined for study inclusion/exclusion by the University Dental
Clinic, who were recruited by the Children’s Dentistry Laboratory of Dental Clinics, Jagiellonian
University, Krakow. Bacterial strains were isolated from plaque samples derived from those
participants (n = 59, mean age: 4.54 ± 0.79 years) who were diagnosed with early childhood caries
(ECC) of the deciduous teeth. ECC was only diagnosed by a clinical examination.
The condition of the children’s dentition was determined in accordance with the guidelines of the
World Health Organization for epidemiological studies on oral health, with the use of the International
Caries Detection and Assessment System (ICDAS) classification. The study group was divided into two
main groups: cavitated (where carious lesions were defined as cavity lesions in fissures and smooth
surfaces with soft bottoms and walls) and non- cavitated (with white or brown enamel discolorations,
but without enamel quantity damage, as well as undiluted enamel without cavities) [36,37].
The non-cavitated group (initial enamel demineralization, or white spots) corresponded to 1–2 in
the ICDAS classification, whereas the cavitated group (dentine or cavitated damage) corresponded to
5–6 in the ICDAS classification [38]. Thirty participants qualified for the non-cavitated group, whereas
29 qualified for the group conventionally referred to as cavitated.
The exclusion criteria included: age below 2 years or over 6 years; inflammatory oral diseases,
other oral diseases such as epithelial dysplasia, and periodontal pathology; and systemic illnesses,
such as diabetes mellitus or hypertension. The use of antibiotics, anti-inflammatory drugs, or steroids,
and a diet rich in supplements, such as vitamins or probiotics, in the past 5 months were also criteria
for exclusion, along with partial or complete rejection of the dental examination by the child or their
legal guardian. Plaque was evaluated, based on the simplified oral hygiene index (OHI-S index) [39].
2.2. Plaque Sampling Methods
Dental plaque was collected using dental probes after the patient’s qualification. Each patient
was instructed about how to prepare for the test. Prior to the decision about giving consent for the
study, details of the study and the scope of application were explained by the investigator. The study
protocol was conducted with respect for the religious values of the study participants. The plaque
samples were collected in the morning, between 8 a.m. and 9 a.m., under fasting conditions, and before
the clinical examination and brushing. Prior to plaque collection, each patient rinsed their mouth
with deionized water. Plaque samples were then placed in tubes containing 0.5 mL of phosphate
buffered saline (PBS), maintained anaerobically. The samples were transported within 2 h at 4 ◦C
to the laboratory. Plaque samples were broken up in an ultrasonic homogenizer (Hielscher UP50H)
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for 30 s at 25% amplitude and gently vortexed to give a homogeneous suspension. Cells were
harvested in a logarithmic growth phase and washed 3 times with 40 mM potassium phosphate buffer
(pH 7.0). Fifty µL of a homogenous microorganism suspension was used in the study for conventional
culture methods, using a Sabouraud medium (Sabouraud Dextrose Agar, SDA) and a HLR-S (HL
Ritz medium containing 40 g tryptic soy agar (TSA), 20% sucrose, 0.3 U/mL bacitracin, 1.75 µg/mL
polymyxin B sulfate and 0.5 µg/mL crystal violet) selective medium, in three 10-fold dilutions, for
each prepared sample. The material was incubated at 37 ◦C for 48 h under microaerophilic conditions
(85% N2, 10% CO2, 5% O2). Positive samples were selected when colony numbers >10,000 cells/mL.
The morphological characteristics of individual colonies cultivated on the medium with sheep blood
were evaluated, as was the type of hemolysis caused by these colonies. In addition, dental plaque
dilutions were performed, and these were inoculated on the Sabouraud medium and on the HLR-S
medium. Once grown, the colonies were counted via determination of CFU/mL (colony forming
units/mL). The number of microorganisms present in a particular test sample was determined using
the formula:
CFU/mL = CFU × dilution factor × 1 aliquot
2.3. Characteristics of Isolated Species of Bacteria and Fungi
Pure S. mutans colonies were inoculated from the selective HLR-S to the Tryptic Soy Agar
(TSA) with 5% sheep blood, as well as the Sabouraud medium, and incubated under the optimal
conditions determined previously. The characteristic appearance of the colonies, including shape, form
(single cells, pseudomycelium cells, or mycelium hyphae), hemolysis factor and other parameters that
may create the phenotype were evaluated. Gram staining was performed every time as an element of
a pre-differential diagnosis (gram-positive and gram-negative bacteria).
2.4. Phenotyping
The species of isolated S. mutans were determined using a commercial STREPTOtest24 bioassay
routine test (Erba Lachema, Brno, Czech Republic) and the API 20C AUX test (bioMérieux, Warsaw,
Poland) for C. albicans.
2.5. Preparation of Microbial Suspensions
S. mutans and C. albicans, isolated from children with ECC, were used in the study. Single S. mutans
and C. albicans colonies were cultured for 8 h at 37 ◦C in the presence of 5% CO2 in 4 mL of the Brain
Heart Infusion medium (Merc, Darmstadt, Germany) and the Sabouraud liquid medium, with the
addition of 5% sucrose, respectively. Bacteria and yeasts were harvested during the logarithmic growth
phase, then washed twice with a 40 mM PBS (pH 7.0).
Microbial growth control was studied by flow cytometry (LSRII, BD Immunoassay Systems,
San Jose, CA, USA). Cell conglomerates and doubles were discarded using a gated width-to-height
spreading (FSC) and lateral scattering (SSC) strategy.
Bacterial and yeast suspensions were standardized to contain approximately 106 CFU/mL.
This was performed by dilution overnight of a bacterial/yeast culture in 5 mL of PBS. The inoculum
density was measured using a MicroSpeak dual densitometer and confirmed by counting single
colonies after 24 h growth under the same conditions as those described for S. mutans (Brain Heart
Infusion Agar BHI agar) and C. albicans (Sabouraud dextrose agar).
2.6. Biofilm Generation
Biofilm generation was determined using a widely accepted, microtiter plate type, where the
biofilm grew on the bottom and the walls of the wells, or on the disks located in the plate wells [40].
Clinical strains of Streptococcus mutans, selected as a pathogenic factor of caries and Candida albicans,
as a potential ECC etiologic factor, were isolated from children with caries and used to form single
or double-species biofilms, as described below. Biofilm formation occurred on polystyrene discs,
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placed vertically at the bottom of the 24-well microtiter plate wells, using sterile handles. Bacterial,
fungal, and bacterial–fungal biofilm growth was investigated in the presence of a probiotic containing
L. salivarius (HM6 Paradens). The crystal violet staining method was used to determine the biomass of
the generated/degraded biofilm [41].
2.6.1. Mono-Species Biofilm
One hundred µL of a standardized bacterial suspension in a Brain Heart Infusion medium
enriched with 5% sucrose of 1 × 106 CFU S. mutans/mL density was added to the wells of the
microtiter plate. One hundred µL of a standardized fungal suspension in a Sabouraud liquid medium
with 5% sucrose of 1 × 104 CFU C. albicans/mL density was added to the other wells. Plates were
incubated for 90 min at 37 ◦C under microaerophilic conditions (85% N2, 10% CO2, 5% O2) to initiate
the attachment of the microorganisms. Afterwards, the wells were washed twice with PBS solution.
Next, 100 µL of FBS (Fetal Bovine Serum) was added to initiate biofilm formation, and the microplates
were incubated for the next 2 h under microaerophilic conditions. Plates were then rinsed twice with
PBS and 50 µL of a tested strain (HM6 Paradens) was added. Fifty µL of PBS (PBS Control), 50 µL of
BHI + 5% sucrose (BHI Control), and 50 µL of Sabouraud + 5% sucrose (Sabouraud Control) were
used as controls. For the biofilm growth and maintenance, 200 µL Sabouraud liquid medium with 5%
sucrose or 200 µL of the BHI medium with 5% sucrose were added to C. albicans and S. mutans wells,
respectively. Microplates were heated at 37 ◦C under microaerophilic conditions for 18, 20, 22, and
24 h (Figure 1).
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2.6.2. Double-Species Biofilm
In the case of double-species S. mutans/C. albicans biofilms, 50 µL of a standardized bacterial
suspension in BHI medium enriched with 5% sucrose of 1 × 106 CFU S. mutans/mL density and
50 µL of a standardized fungal suspension in a Sabouraud liquid medium with 5% sucrose of
1 × 104 CFU C. albicans/mL density were added to the wells. Plates were incubated for 90 min
at 37 ◦C under microaerophilic conditions (85% N2, 10% CO2, 5% O2) to initiate the attachment of
the microorganisms. Afterwards, the wells were washed twice with PBS solution. Next, 100 µL FBS
(Fetal Bovine Serum) was added to initiate biofilm formation, and the microplates were incubated for
the next 2 h under microaerophilic conditions. Plates were then rinsed twice with PBS and 50 µL of
a tested strain (HM6 Paradens) was added. Fifty µL of PBS (PBS Control), 50 µL of BHI + 5% sucrose
(BHI Control), and 50 µL of Sabouraud + 5% sucrose (Sabouraud Control) were used as controls.
For the C. albicans/S. mutans biofilm growth, 100 µL Sabouraud liquid medium with 5% sucrose and
100 µL of the BHI medium with 5% sucrose were added to the wells containing both C. albicans and
S. mutans. Microplates were heated at 37 ◦C under microaerophilic conditions for 18, 20, 22, and 24 h
(Figure 1).
Microorganism proportions in the wells were similar to those found in saliva samples in children
with ECC. The organisms were grown without interruption, to allow generation and formation of
biofilm, for 18, 20, 22 and 24 h, until the end of the experimental period.
2.7. Bacterial Enumeration (CFU/mL) in Biofilms
The biofilms were washed thrice with phosphate-buffered saline at different time points
(after 18, 20, 22, 24 h of incubation). The biofilm generated at the bottom of the well was removed
by blending in an ultrasonic homogenizer (Hielscher UP50H, Teltow, Germany) for 20 s at 25%
amplitude. Serial dilutions of the resultant solution were prepared and seeded in amounts of 100 µL
on Sabouraud agar for C. albicans and mitis salivarius-bacitracin agar with sucrose MSBS (containing
bacitracin and sucrose) for S. mutans, and then their growth was promoted for the next 48 h under
microaerophilic conditions. The colony forming units (CFU/mL) were indicated. The protocol was
performed in triplicate.
2.8. Biofilm Mass Determination
The mass of any formed biofilm was determined at different time points (after 18, 20, 22, 24 h of
growth) via the crystal violet method. The formed biofilm was fixed in methanol (99+%, Sigma–Aldrich,
Poznan, Poland) for 20 min. Then, the supernatants were discarded and the plates were air dried.
Next, 125 µL of crystal violet (CV, 0.1%) solution was pipetted to microtiter plate wells. CV excess
was removed by 3-fold PBS washing. The bounded stain was released with 200 µL of 95% ethanol
(Sigma–Aldrich, Poznan, Poland). Subsequently, the contents of the wells were pipetted and 125 µL
of the suspension was carried out to the new plate. The biomass of the generated biofilm was
determined through its measured absorbance, using the standard curve at the maximum wavelength
(λmax) = 540 nm. The protocol was performed at 20 to 25 ◦C twice at different times. The biofilm
generation curve was plotted.
2.9. Scanning Electron Microscopic Analysis of Biofilm
Microbial biofilms were grown on 13 mm diameter round basic slides (Agar Scientific, Stansted,
UK) in the wells of a 24-well plate, according to the protocol described above.
The slides were then stabilized in 1 mL of a 2.5% glutaraldehyde for 1 h and dehydrated in
serial dilutions (50, 70, 80, 90, 95, 100% v/v) of ethanol for 20 min. Subsequently, the slides were
immersed in 100% ethanol for 1 h. The slides were air-dried for one day and then transferred to copper
disks and dusted with gold (160 s, 40 mA). The samples were analyzed using a scanning electron
microscope (JEOL JSM-35CF, SEM, Jeol, Japan) at 20–25 kV in the Laboratory of the Otolaryngology
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Clinic, University Hospital, Krakow. The protocol was conducted at the above-mentioned time points
in triplicate.
2.10. Statistical Methods
A statistical analysis was performed using R 3.2.3 (R Development Core Team, 2009). The ages
of the children from the two subgroups were compared using Fisher’s exact test (because of the low
expected numbers in the contingency table). The Shapiro–Wilk test was used to verify the normality
of the data. Non-parametric analyses were conducted. Data are demonstrated as median and range.
To compare CFU (log-transformed) and the optical density (OD) between S. mutans, C. albicans, and
the co-culture, the Kruskal–Wallis test was performed. Dunn’s test (post-hoc test) was performed to
determine which of the 3 groups actually differed.
The paired Wilcoxon’s test was used to compare CFU (log-transformed) and the optical density
(OD), before and after Lactobacillus salivarius (HM6 Paradens) administration. Spearman’s coefficient
of correlation was used to evaluate the relationship between colony-forming units (log-transformed)
and the optical density (p < 0.05 indicated a statistically significant result).
3. Results
3.1. Study Design
During the study, bacterial and fungal strains were isolated from the plaque of children (n = 59,
mean age: 4.54 ± 0.79 years) who were diagnosed with ECC of deciduous teeth.
Participants were assigned to two subgroups: children with early enamel deamination
(white spots), defined as “non-cavitated” (n = 30; 1–2 in the ICDAS code); and children with dentin
damage, assigned to the “cavitated” group (n = 29; 5–6 in the ICDAS code) [38]. Thirty participants,
including 11 girls (4.91 ± 1.04 year/o) and 19 boys (4.47 ± 0.61 year/o), were allotted to the
“non-cavitated” group, while 29 children to the “cavitated” one (14 girls aged 4.43 ± 0.94 years
and 15 boys aged 4.47 ± 0.64 years). The form of caries did not depend on age, as shown in Table 1.
Table 1. Division of study groups according to patient age.
Examined
Groups
Age: 3 Years (n = 6) Age: 4 Years (n = 20) Age: 5 Years (n = 28) Age: 6 Years (n = 5) p *
n n n n
Non-cavitated 2 11 13 4 0.489
Cavitated 4 9 15 1
* Fisher’s exact test (because of the low numbers in the table).
3.2. Morphological Characterization of Isolated Species of Bacteria and Fungi
Interactions among C. albicans and S. mutans groups can create the biofilm demonstrated
in Figure 2A–C. The isolated species of bacteria and fungi are listed in Table 2.
Table 2. Frequency of isolation of S. mutans and yeasts in the studied groups of patients.
Microorganisms Girls (n = 25) Boys (n = 34) Total (n = 59)
n n n
C. albicans 12 18 30
S. mutans 13 16 29
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3.3. Analysis of Biofilm before and after Incubation with L. salivarius Probiotic
Differences in the colony forming units (CFU/mL) and the total biofilm mass of microorganisms
(C. albicans, S. mutans, and the co-culture) at 18, 20, 22, and 24 h were statistically significant (Figure 3).
The inhibitory effect of Lactobacillus salivarius (HM6 Paradens) on biofilm generation by S. mutans,
yeasts, and the co-culture is shown in Figures 3 and 4, and the scanning electron microscope images
(Figures 5B,D,F 6–7 and 8B,D,F) after 24 h biofilm formation. The photographs show morphologically
different fungal colonies and bacterial cells in single and co-cultures, before and after the administration
of Lactobacillus salivarius.
The quantities of microorganisms’ (S. mutans, C. albicans, and the co-culture) logCFU/mL forming
biofilms at 18, 20, 22, and 24 h were statistically lower after the administration of a probiotic in all
analyzed groups (Figures 3, 5 and 6). The p value was statistically significant for 18–24 h points.
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using a sucrose-dependent mechanism; (B) The 24 h S. mutans biofilm formed on a flat agar surface;
visible polymeric Extracellular Matrix (ECM), which has an open architecture with nutrient channels,
and other properties; (C) The 24 h C. albicans biofilm formed on a flat agar surface (Agar Scientific,
Stansted, UK). C. albicans adheres to the polystyrene surface, mainly using mycelial forms, visible
pseudohyphae, budding yeast, and the so-called germ tube, considered to be the key features of the
pathogenicity of the fungus. The culture was maintained at 36 ◦C, pH 7.0 and pCO2 5%, in bovine
serum as a medium additive promoting growth of the culture in the presence of a sucrose substrate
(5%); (D) The 24 h C. albicans biofilm formed on a flat agar surface (Agar Scientific, Stansted, UK) under
the influence of Lactobacillus salivarius (HM6 Paradens). There was no clear, compact structure for the
C. albicans biofilm and single loosely located budding cells. Other morphological forms of yeasts were
invisible; (E) The 24 h double-species oral streptococci/yeasts biofilm formed on a flat agar surface
(Agar Scientific, Stansted, UK). There was an apparent change in the C. albicans morphotype in the
S. mutans common culture and visible pleomorphic forms were true hyphae and, blastoconidia, which
in the mixed culture also produce mycelial forms, whose role is related to damage to immune cells
(macrophages), leading to microorganism invasion. There was abundant extracellular matrix between
cells and covering bacterial and yeast cells. Bacterial cells were visible in chains adhering to yeast
cells and wrapped around them; (F) The 24 h double-species S. mutans/C. albicans biofilm formed
on a flat agar surface (Agar Scientific, Stansted, UK) under the influence of Lactobacillus salivarius
(HM6 Paradens). There was no clear, compact S. mutans/C. albicans biofilm structure or single loosely
located budding cells. Other morphological forms of C. albicans were invisible. There was no visible
extracellular matrix. Original magnification: 4000× and 6000×.
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The median (range) bacterial count log(CFU/mL) value for single-species S. mutans biofilm after
24 h was 7.643 (7.568–7.756) and was significantly higher than the bacterial count log(CFU/mL)
after probiotic administration: 7.505 (7.415–7.623) (Kruskal–Wallis test for dependent (repeated)
measurements; p < 0.05) (Figures 3 and 6).
The median (range) bacterial count log(CFU/mL) value for single-species C. albicans biofilm after
24 h was 6.279 (6.114–6.462) and was significantly higher than the bacterial count log(CFU/mL)
after probiotic administration: 5.900 (5.833–5.991) (Kruskal–Wallis test for dependent (repeated)
measurements; p < 0.05) (Figures 3 and 6).
The median (range) bacteria/fungi count log(CFU/mL) value for double-species
S. mutans/C. albicans biofilm after 24 h was 9.267 (9.041–9.477) and was significantly higher
than the log(CFU/mL) after probiotic administration: 8.816 (8.633–8.940) (Kruskal–Wallis test for
dependent (repeated) measurements; p < 0.05) (Figures 3 and 6).
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Figure 8. SEM images of the mono-species biofilm generated by C. albicans, S. mutans and the double-
species oral streptococci/yeasts biofilm—untreated and treated with the Lactobacillus salivarius (HM6 
Paradens)—after 24 h of biofilm formation. (A) The 24 h C. albicans biofilm formed on a flat agar 
surface (Agar Scientific, Stansted, UK); (B) The 24 h C. albicans biofilm formed on a flat agar surface 
Figure 7. S. mutans, C. albicans, and oral streptococci/yeast biofilm formation: changes in optical
density (OD) of biofilm mass, before and after administration of Lactobacillus salivarius (HM6 Paradens)
after 24 h. Wilcoxon’s test was used for dependent (repeated) measurements (paired Wilcoxon’s test;
p < 0.05). Data are represented as median ± 1–3 quartiles for three experiments. *** Indicates statistically
significant difference compared to untreated biofilms (p < 0.001).
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Figure 8. SEM images of the mono-species biofilm generated by C. albicans, S. mutans and the
double-species oral str ptococci/yeasts biofilm—untreated and treated with the Lactobacillus salivarius
(HM6 Paradens)—after 24 h of biofilm formation. (A) The 24 h C. albicans biofilm formed on a flat
agar surface (Agar Scientific, Stansted, UK); (B) The 24 h C. albicans biofilm formed on a flat agar
surface treated with the Lactobacillus salivarius (HM6 Paradens); (C) The 24 h S. mutans biofilm
formed on a flat agar surface (Agar Scientific, UK); (D) The 24 h S. mutans biofilm formed on
a flat agar surface treated with the Lactobacillus salivarius (HM6 Paradens); (E) Co-culture oral
streptococci/yeasts biofilm—untreated with the Lactobacillus salivarius (HM6 Paradens)—after 24 h
of biofilm formation; (F) Co-culture oral streptococci/yeasts biofilm—treated with the Lactobacillus
salivarius (HM6 Paradens)—after 24 h of biofilm formation. The Culture was maintained at 36 ◦C,
pH 7.0 and pCO2 5%, in bovine serum as a medium additive promoting growth of the culture in the
presence of a sucrose substrate (5%). The occurrence of a co-culture biofilm at this stage may depend
on the C. albicans morphotypes showing a twofold nature: buds and C. albicans hyphae may colonize
mucous membranes and constitute physiological microflora (commensal) or may lead to infection
under favorable conditions (opportunistic pathogens). There was no clear, compact structure for the
C. albicans biofilm and single loosely located budding cells. Other pathological forms of yeasts are
invisible. There was an apparent change in the C. albicans morphotype in the S. mutans common
culture and visible pleomorphic forms were true hyphae, blastoconidia, which in the mixed culture
also produce mycelial forms, whose role is related to damage to immune cells (macrophages) leading
to microorganism invasion. There was abundant extracellular matrix between cells and covering
bacterial and yeast cells. Bacterial cells were visible in chains adhering to yeast cells and wrapped
around them. There was no clear, compact S. mutans/C. albicans biofilm structure or single loosely
located budding cells. Other morphological forms of C. albicans were invisible. There was no visible
extracellular matrix (D,F), which is formed by S. mutans alone and S. mutans with C. albicans treated
with the Lactobacillus salivarius (C,E). Original magnification: 400×, 4000× and 6000×.
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3.4. Analysis of Formed Biofilm Mass before and after Incubation with L. salivarius Probiotic
The total biomass (OD) of microorganisms (S. mutans, C. albicans, and the co-culture) producing
a biofilm at 18, 20, 22, and 24 h were statistically lower after the administration of the probiotic in all
the analyzed groups. The p value was statistically significant for all time points (18–24 h) (Table 3).
The inhibitory effect of L. salivarius (HM6 Paradens) on biofilm generation by S. mutans, yeasts,
and the co-culture is shown in Table 3 and Figures 4 and 7 after a 24 h biofilm formation.
The mean biofilm mass (OD) value for single-species S. mutans biofilm after 24 h was 0.139 ± 0.007
and was significantly higher than the OD value after probiotic administration: 0.131 ± 0.004 (paired
Wilcoxon’s test; p < 0.001) (Figures 4 and 7).
The mean biofilm mass (OD) value for single-species C. albicans biofilm after 24 h was 0.100 ± 0.013
and was significantly higher than the OD value after probiotic administration: 0.084 ± 0.006 (paired
Wilcoxon’s test; p < 0.001) (Figures 4 and 7).
The mean biofilm mass OD value for double-species S. mutans/C. albicans biofilm after 24 h
were 0.176 ± 0.024 and was significantly higher than the OD value after probiotic administration:
0.127 ± 0.005 (paired Wilcoxon’s test; p < 0.001) (Figures 4 and 7).
Table 3. S. mutans, C. albicans, and oral streptococci/yeast biofilm formation: total biomass (OD)
evaluation before and after administration of Lactobacillus salivarius (HM6 Paradens, LS) at individual
time points.
Species Time Test n Mean SD Median Min Max Q1 Q3 p ***
S. mutans
18 h
Before LS 29 0.134 0.005 0.132 0.125 0.143 0.130 0.138 <0.001
After LS 29 0.127 0.005 0.127 0.119 0.135 0.122 0.130
20 h
Before LS 29 0.136 0.005 0.134 0.128 0.145 0.132 0.141 <0.001
After LS 29 0.128 0.005 0.128 0.120 0.137 0.124 0.132
22 h
Before LS 29 0.138 0.006 0.136 0.129 0.148 0.134 0.143 <0.001
After LS 29 0.130 0.005 0.130 0.121 0.139 0.126 0.134
24 h
Before LS 29 0.139 0.007 0.136 0.129 0.154 0.135 0.144 <0.001
After LS 29 0.131 0.004 0.131 0.123 0.140 0.126 0.134
C.
albicans
18 h
Before LS 30 0.095 0.013 0.094 0.070 0.120 0.084 0.106 <0.001
After LS 30 0.078 0.006 0.080 0.070 0.092 0.074 0.082
20 h
Before LS 30 0.098 0.013 0.097 0.072 0.123 0.086 0.108 <0.001
After LS 30 0.081 0.006 0.082 0.072 0.094 0.076 0.084
22 h
Before LS 30 0.100 0.013 0.100 0.074 0.125 0.088 0.110 <0.001
After LS 30 0.083 0.006 0.084 0.074 0.096 0.078 0.086
24 h
Before LS 30 0.100 0.013 0.101 0.075 0.126 0.089 0.111 <0.001
After LS 30 0.084 0.006 0.085 0.074 0.097 0.080 0.086
S.
mutans/C.
albicans
18 h
Before LS 29 0.171 0.024 0.179 0.125 0.221 0.151 0.191 <0.001
After LS 29 0.123 0.006 0.122 0.112 0.131 0.118 0.129
20 h
Before LS 29 0.173 0.024 0.181 0.127 0.224 0.154 0.193 <0.001
After LS 29 0.125 0.006 0.124 0.114 0.134 0.120 0.130
22 h
Before LS 29 0.175 0.024 0.183 0.129 0.226 0.156 0.195 <0.001
After LS 29 0.127 0.005 0.126 0.115 0.134 0.123 0.132
24 h
Before LS 29 0.176 0.024 0.184 0.130 0.228 0.157 0.194 <0.001
After LS 29 0.127 0.005 0.127 0.117 0.134 0.123 0.132
Wilcoxon’s test was used for dependent (repeated) measurements (paired Wilcoxon’s test; * p < 0.05, *** p < 0.001).
SD, standard deviation.
3.5. Relationship between the Colony Forming Unit Log(CFU/mL) and the Biofilm Mass (OD) before and after
Lactobacillus salivarius Administration
A correlation was noted between the microorganisms forming a biofilm (log(CFU/mL) and
their mass (optical density) at the considered time points (Figure 9). After the administration of
Lactobacillus salivarius (HM6 Paradens), the correlation between colony forming units and the S. mutans,
the biofilm mass (OD) was lower or not present at all (Figure 10 and Table 4). For the C. albicans and
Nutrients 2017, 9, 1242 14 of 23
S. mutans/C. albicans biofilms, no correlation between log(CFU/mL) and biofilm biomass (OD) was
observed (Table 4).
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Figure 9. Correlations between the number of microorganisms forming a biofilm (S. mutans)
(log(CFU/mL) and the optical density (biofilm mass) after 18 (A), 20 (B), 22 (C), and 24 (D) h of
incubation, before Lactobacillus salivarius probiotic administration.
Table 4. Correlations between the number of microorganisms forming a biofilm (S. mutans, C. albicans,
and S. mutans/C. albicans) and the optical density (biofilm mass, OD) at different time points, before
and after Lactobacillus salivarius (HM6 Paradens, LS) administration.
Species Incubation
Time
Before LS After LS
r p r p
S. mutans
18 h 0.495 0.006 0.371 0.048
20 h 0.534 0.003 0.379 0.043
22 h 0.500 0.006 0.502 0.005
24 h 0.553 0.002 0.473 0.009
C. albicans
18 h 0.920 <0.001 0.136 0.473
20 h 0.918 <0.001 0.128 0.927
22 h 0.931 <0.001 0.127 0.888
24 h 0.935 <0.001 0.135 0.853
S. mutans/C.
albicans
18 h 0.764 <0.001 0.181 0.337
20 h 0.769 <0.001 0.191 0.393
22 h 0.766 <0.001 0.200 0.459
24 h 0.842 <0.001 0.192 0.628
The observed correlation was statistically significant throughout the biofilm generation (p < 0.05).
The following connection was positive: the higher the number of colony forming units of tested
microorganisms the higher optical density (biofilm mass). The strongest associations were reported
after 24 h of biofilm generation (Table 4).
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4. Discussion
The formation of biofilm on the surface of the teeth is a major factor in the development of
early childhood caries (ECC) [1]. Studies have shown that bacteria and fungi present in biofilms may
communicate with each other by sending extracellular signaling molecules or physical intercellular
interactions to support the formation and development of cariogenic biofilms that contribute to the
progression and recurrence of ECC [42].
The multifactorial etiology of the disease makes it necessary to perform a complex evaluation.
The main causes include mutual host-microbial interactions, changes in mixed biofilms (reflecting
both the richness of the microorganisms of the oral cavity and its conditions), and external factors
initiating continuous pH changes in dental plaque. Stress factors associated with a reduction in the
pH of the oral environment are responsible for the decreasing diversity of bacterial species that form
oral biofilms. This results in minimization of metabolic activity (particularly, pyruvate kinase as
the key enzyme for the entire process) and structural damage to the cell membrane, proteins, and
DNA [43,44]. Hence, there are few species of microorganisms able to have an active metabolism under
the above-mentioned conditions [45]. Dental plaque is associated with oral conditions associated with
a drop in pH, resulting in the dominance of acid-producing strains connected to the development
of caries. In physiological conditions, saprophytic/probiotic bacteria maintain the microbial balance
and do not allow pathogenic flora to overgrow. The present paper describes the effect of a probiotic
containing L. salivarius (HM6 Paradens) on a double-species biofilm of S. mutans/C. albicans as a new
approach to maintaining the interspecies balance in the oral cavity and an additional method for
supporting existing caries prevention methods.
A number of clinical studies have indicated that daily intake of Lactobacillus-derived dairy
products can reduce caries, improve overall health, and reduce the need for antibiotic use in preschool
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children. However, not all children eat dairy products equally rich in probiotic substances. In addition,
the impact of probiotics on oral health and caries inhibition in children is not entirely clear; further,
their effects appear to be short-lived and are often directed exclusively at the reduction of cariogenic
S. mutans, without affecting other microbial species colonizing the oral cavity that have been confirmed
to contribute to caries development.
As a result of advanced technology, the number of documented microorganism species involved
in the development of caries is increasing. There are literature data indicating that, in addition to
S. mutans and C. albicans, fungi are involved in the carious process and are detectable in large amounts
in the plaque and saliva of children with ECC [1,26,45–47].
Bacterial–fungal infections are common in humans, as part of the natural physiological flora.
Under favorable conditions, microorganisms that have been thus far regarded as saprophytes incapable
of inducing human diseases and have become an etiological factor in a number of diseases [3,48].
C. albicans, as a main representative of a fungal microbiome, is present in the mouth, in the mucous
membranes, dentures, and orthodontic devices [49,50]. However, a number of observations have
indicated that interactions between yeasts and oral streptococci can also occur on cleansed surfaces of
enamel, dentine, or on the surface of dental plaque [51,52], particularly in the presence of nutrients,
such as sucrose [53,54].
We demonstrated that in the presence of a probiotic, containing inactivated L. salivarius
(HM6 Paradens), biofilm formation was different from that in a double-species model, without the use
of the probiotic. After a suitable culture time, there was no observable mixed S. mutans and C. albicans
biofilm formation. Single aggregates of yeasts and streptococci did not produce a common structure,
as in the double-species model. This suggests that L. salivarius perhaps competes with S. mutans for
nutrient substrates and does not allow these bacteria to consume them, along with inhibiting the
aggregation of oral streptococci and yeasts, thus resulting in the lack of a double-species biofilm
structure. It is necessary to carry out studies that would either provide or deprive biofilms of certain
nutrients, in order to confirm the hypothesis of a possible mechanism.
In this study, CFU/mL results showed a higher number of C. albicans in mixed C. albicans/S. mutans
biofilms, compared to single-species C. albicans biofilms, indicating that S. mutans stimulate C. albicans
growth. These results coincide with those of Júnia Oliveira Barbos et al. and Tomé et al. [55,56].
Although the molecular mechanism for these behaviors is undefined, He et al. [57] confirmed
that the interaction between S. mutans and C. albicans is related to the upregulation of most
carbohydrate-transport-linked genes and metabolic processes. The presence of C. albicans enhances the
expression of 393 genes in S. mutans in the double-species biofilm, as compared to the single S. mutans
biofilm. Molecular studies have shown that the coexistence of S. mutans with C. albicans affects the use
of carbohydrates by S. mutans. Furthermore, a co-culture with C. albicans changes the transcription of
S. mutans signal transduction genes (comC and ciaRH) associated with its condition and virulence [3].
Occurrence of a biofilm at this stage may depend on the C. albicans morphotypes showing a twofold
nature: buds and C. albicans hyphae may colonize mucous membranes and constitute physiological
microflora (commensal) or may lead to infection under favorable conditions (opportunistic pathogens).
These data provide extensive evidence for bacterial–fungal interactions that may progress to dental
caries or recurrence of the disease in the future.
During initial adhesion of pioneer colonizers, such as S. mutans, to an enamel surface, there
is increased activation of glucosyltransferases (Gtfs), particularly GtfB. These, in turn, become the
binding sites of secondary colonizers, such as C. albicans and S. mutans [58]. Fungi, occurring in
a hyphal form [59], exhibit better adhesion to the surface than blastospores. However, these effects
are not as strong as when C. albicans is present in association with S. mutans [24], as stated in the
literature. This is probably related to increased levels of proteolytic enzymes, i.e., aspartyl proteinases
(Saps) of C. albicans, which increase mutual interspecies interactions. In particular, Sap1–5 dominate
in dental biofilms and can be a crucial factor in ECC development [60,61]. These, and a number
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of other, yet unknown, unique effects enhance the adhesion properties of both microorganisms for
teeth colonization.
In terms of the double-species S. mutans/C. albicans biofilm, one can note that fungi occurring in
the form of hyphae and blastoconidia are much better at biofilm-producing than in the absence of
these forms, under the action of the L. salivarius probiotic (HM6 Paradens), as seen in scanning electron
microscope images (Figure 4C,D). This formulation can act as a proteolytic enzyme inhibitor, i.e.,
aspartyl proteases (Saps) of C. albicans, which are considered to be the main contributor to interspecies
interactions. The above observation is quite innovative, since research on S. mutans and C. albicans
biofilms has confirmed that S. mutans stimulates C. albicans to grow as biofilms in vitro. However, it
has been thought so far that the bacteria inhibit the formation of hypha by yeast [51]. In our studies
on clinical strains from children with childhood caries, the opposite effect can be observed. In SEM
samples, double-species biofilms were plentiful in hyphae formed by fungi, which was not noticeable
after a probiotic application. When evaluating the fungal morphology, we noticed that L. salivarius
inhibited the formation of germ tubes and pseudomycelium when added to the S. mutans and C. albicans
common culture. These observations indicate that this probiotic may produce signaling molecules or
indirectly inhibit the generation of double-species biofilm by inhibiting S. mutans. Without the use of
a probiotic, S. mutans supported the cariogenicity of the biofilm. In the presence of HM6, C. albicans
mycelium was not formed in a mixed biofilm. The present model seems interesting, due to the fact
that, thus far, it has been presumed that it is S. mutans in the C. albicans mixed biofilm that sends
signaling molecules, such as mutanobactin A, that naturally inhibit C. albicans hyphae, thus preventing
the development of cariogenic biofilms.
This results in increased production of the EPS biofilm matrix and a specific hyperadditive effect
that enhances the biofilm virulence. C. albicans dominates in the competition for unique eco-niches,
such as teeth gaps and fractures [62], and, using its natural ability for thigmotropism, penetrates
deep into the open dental canals. Owing to increased penetration of hard-to-reach places, such
as tooth roots, C. albicans leads to aggressive caries and contributes to rapid progression of the
disease [63,64]. It is necessary to further study the mechanisms of multispecies interactions of yeasts
and oral streptococci in the biofilms during which EPS growth and the activation of metabolic pathways
has a significant impact on the aggressiveness of the formed structure and the rapid progression
of the disease. The results of this study explain why current caries prophylaxis, based only on
S. mutans identification, is not as effective as screening methods for diagnosing children at risk
for early caries. Research should be conducted on the mutual relationships between potentially
interacting microorganisms (pathogenic and non-pathogenic). An approach, based on the current state
of knowledge on caries, increases the chances of understanding the pathogenesis of this disease and
may, therefore, lead to new ways of prevention. Then, it will be possible to design potential modulators
for the development and progression of diseases, such as caries.
The studies on the S. mutans/C. albicans interactions cited earlier in this work concerned biofilm
models using in vitro reference strains. The presented model uses clinical strains and shows the
variability that clinical strains may exhibit, even within the same species. The same strain does not
necessarily induce a hostile response to disease development. Calculation of the pathogenic effect
for microorganisms appears to be estimative and despite an inoculum-dependent effect, there are
still other limitations, such as the occurrence of variable conditions of infection [65]. Comparisons of
virulence among microorganisms provide evidence that any action aimed at eliminating its factors
should be undertaken with caution, given that any change in the host–microbial relationship can alter
the pathogenic potential of microorganisms.
Although in vivo studies seem to be much more reflective of the real situation, they are becoming
increasingly limited due to ethical reasons.
Application of an in vivo model, using potentially cariogenic clinical strains, and evaluation of
the effect of Lactobacillus salivarius (HM6 Paradens) probiotic on C. albicans/S. mutans co-culture biofilm
were the objectives of this study.
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This observation demonstrates that a probiotic containing thermally inactivated L. salivarius
strains inhibited the ability of the strains to form a common structure between oral streptococci and
yeasts. The examined strains were derived from the dental biofilm of children with early childhood
caries. The evaluation of the generated biofilm under the influence of the test compound showed
a decrease in both the grown colonies and the biofilm biomass, along with reduced cross-linking
of the biofilm structure. These results coincide with those of Wu et al. [66], Ahmed et al. [67], and
Nishihara et al. [15].
The obtained results are of interest because a number of studies using probiotics appear to
be controversial, particularly as probiotics that inhibit the growth of S. mutans monocultures do
not necessarily reduce the cariogenicity of multi-species biofilms [68], where S. mutans is only one
component among a number of other plaque-forming species [69]. Therefore, it seems more appropriate
to study the effect of probiotics on the relationships between the different biofilm-forming species
and the reduction of cariogenic S. mutans. In addition, the above data on the inhibition of biofilm
formation, not only of S. mutans but also by the S. mutans/C. albicans co-culture, indicate that the action
of the Lactobacillus salivarius (HM6 Paradens) is very promising. It meets the modern definition of
caries as a multifactorial disease [70], which is dependent on a number of species of microorganisms
forming biofilms and not just on selected single species of bacteria [71]. Furthermore, the findings
support the assumption of Koo and Bowen [72], who proposed the possibility of including anti-fungal
(anti-Candida) therapy for ECC.
Although there are many published studies showing the mutual interactions of fungi with
bacteria, including S. mutans, most of the mechanisms responsible for these processes remain
unclear. Recently, several key findings have emerged that characterize the molecules involved in
the S. mutans/C. albicans interactions. However, these models do not take into account the factors
connected to the host and pathogenicity of the strains depending on the host environment. It is known
that under certain conditions, bacteria or fungi acquire features that condition their pathogenicity [65].
Our model has the advantage of taking into account clinical strains from the source of infection
(dental plaque from children with caries), which have developed their virulence in response to the
environment where they exist. This is confirmed by the results on interactions between S. mutans and
C. albicans clinical strains, which produce pathogenic factors such as mycelia and germ tubes in the
co-culture. This is constrast to the results obtained by other researchers (using standard strains), where
such factors were not present. International research uses advanced technology, but such technology
is not always or everywhere accessible and applicable. Thus, the observations obtained during
the presented studies are unique because they show changes in the level of fungal morphogenesis
associated with the production of mycelium. In clinical practice, this is a manifestation of C. albicans
pathogenesis, associated with an active infection, which is severe caries. Continuing the observed
relationships, in the future we would like to evaluate hyphal growth factor HWP1, or ALS1 and ALS3,
which, as seen in studies by Ellepola et al. [42], may be a potential mechanism of mycelial growth in
S. mutans/C. albicans co-cultures. We plan to verify how available nutrients, except sucrose, modify
the above-mentioned feature. This new discovery may explain the mutual roles of S. mutans and
C. albicans in cariogenic biofilm formation and provide a point of action for the creation or utilization
of molecules with antineoplastic potential. The results of the study on the inhibition of cariogenic
S. mutans/C. albicans biofilm are also a prerequisite for further research on this probiotic in in vivo
studies. In addition, the multifunctional nature of biofilm development and resistance to conventional
treatment encourage the use of probiotics, which are intended to protect native microflora by interfering
with microorganisms accumulated in the biofilm structure.
Probiotic bacteria, such as L. salivarius, colonize the oral cavity of naturally born children [73].
Their protective role may be based on the stimulation of the host’s immune system to produce
antibodies and immunoglobulins [74]. The results of the potential use of probiotics in caries are very
encouraging. Our study, although a small section of probiotic research, encourages us to take further
steps to establish a consensus on the use of probiotics in the prevention of oral diseases, such as dental
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caries. The research is important, as the available databases have only a few clinical studies with strong
scientific evidence proving the effectiveness of probiotics in ECC counteraction [64].
5. Conclusions
Research on the use of probiotics in the prevention of oral diseases, such as dental caries, has
opened up new opportunities for establishing a balance between diet and oral health. Studies show
that probiotic bacteria given in any form are safe for humans and can provide a good complement
to daily oral hygiene. Administering probiotics based on the occurrence of a natural comorbid flora
in our organism is the future of biotherapeutic research, as these bacteria are ideally adapted to the
human microbiome and occupy the supreme position while displacing potentially pathogenic species.
Probiotic supplementation to a daily balanced diet may be a strategy for preventing caries or other
oral infectious diseases in children.
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